Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

27 mai 2026 08h45 HE | Source: 24/7 Market News

Breakthrough Pipelines Ignite Investor Excitement: Retatrutide, VERVE-102, NEO100, and More Set to Transform Medicine

Phase 2 and Phase 3 trials are reshaping expectations across obesity, oncology, gene editing, autoimmune disease, and neurological disorders.
14 avr. 2021 08h00 HE | Source: Portnoy Law

Immunovant, Inc. Technology Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

Investors with losses are encouraged to contact the firm before April 20, 2021; click here to submit trade information LOS ANGELES, April 14, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises...
10 févr. 2021 08h00 HE | Source: Portnoy Law

Immunovant, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Immunovant, Inc. ("Immunovant"...